首页> 美国卫生研究院文献>ISRN Pharmacology >Potential Agents against Plasma Leakage
【2h】

Potential Agents against Plasma Leakage

机译:潜在的血浆泄漏防护剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Shock due to severe plasma leakage may happen in infectious diseases such as severe dengue and sepsis due to various bacterial infections, which may be deleterious and may lead to death. Various substances and proteins are known to modulate the effects of proleakage mediators and counteract the deleterious effect of plasma leakage. Some of the various substances and proteins such as focal adhesion kinase (FAK), the Rho GTPases, protein kinase A, and caveolin-1 have dual actions; therefore they are not suitable for therapy. However, sphingosine 1phosphate and its receptor agonists, Angiopoetin-1, Slit, and Bbeta15–42 may be promising.
机译:在严重的登革热和败血症等感染性疾病中,由于各种细菌感染引起的严重血浆泄漏引起的休克可能会造成有害并导致死亡。已知各种物质和蛋白质可调节渗漏介体的作用并抵消血浆渗漏的有害作用。一些不同的物质和蛋白质,例如粘着斑激酶(FAK),Rho GTPases,蛋白质激酶A和Caveolin-1具有双重作用。因此它们不适合治疗。但是,鞘氨醇1磷酸及其受体激动剂Angiopoetin-1,Slit和Bbeta15-42可能很有希望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号